Survey reveals less than half of Americans plan to get flu shot this season
A survey conducted by the National Foundation for Infectious Diseases (NFID) revealed that only 49 percent of polled U.S. adults plan to get a flu shot this season, CNBC reports.
The data shows that 1 in 5 respondents at higher risk for influenza-related complications reported that they do not plan to get the annual vaccine this season. People over 65 years old, pregnant people, patients with underlying conditions, and children under five face a significant risk of severe outcomes if infected with the flu, per the Centers for Disease Control and Prevention.
The NFID survey found that while nearly 70 percent of people agreed that the annual flu shot was the best way to prevent fatal influenza infections, many are still electing not to get the vaccine this year. CNBC reports that 58 percent of the Americans surveyed plan to wear masks at least part of the time to protect themselves during flu season, which exceeds the number who plan to get the shot.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Per the NFID survey, some of the top reasons for not getting the vaccine include believing that the flu shot is ineffective and concerns over potential side effects.
"With COVID, people have forgotten about influenza," said William Schaffner, medical director of NFID, at an NFID conference on Tuesday. "This is another serious winter respiratory virus, it can do bad damage to you. The key to prevention is vaccination."
The survey polled 1,005 adult respondents throughout the United States and was conducted via phone and web between Aug. 11 and 15. The overall margin of error is +/- 4.2 percentage points.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and cannabis industry news.
-
Will auto safety be diminished in Trump's second administration?
Today's Big Question The president-elect has reportedly considered scrapping a mandatory crash-reporting rule
By Justin Klawans, The Week US Published
-
One great cookbook: 'A Girl and Her Greens' by April Bloomfield
The Week Recommends Vegetables deserve the best. In this chef-author's hands, they achieve their ultimate potential.
By Scott Hocker, The Week US Published
-
DeSantis appoints Florida's top lawyer to US Senate
Speed Read The state's attorney general, Ashley Moody, will replace Sen. Marco Rubio in the Senate
By Rafi Schwartz, The Week US Published
-
The decline of the contraceptive pill
In the Spotlight Fears of the pill's side effects, stoked by social media, behind switch to fertility trackers – or no contraception at all
By Harriet Marsden, The Week UK Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
Walking pneumonia cases are picking up pace
The explainer Another respiratory illness to be wary of
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
The future of fluoridated water is up for debate
The Explainer The oral benefits are watery
By Devika Rao, The Week US Published
-
Will the murder of a health insurance CEO cause an industry reckoning?
Today's Big Question UnitedHealthcare CEO Brian Thompson was shot and killed in what police believe was a targeted attack
By Justin Klawans, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published